Select Page

Universal Access and Affordable Medicines

Our campaign promotes transparency, accountability and the public interest in the field of pharmaceuticals. Our evidence-based advocacy aims to guarantee better and affordable medicines for Europe by questioning and reforming the current pharmaceutical business model and calling for better access to medicines for all.

About our work on access to medicines

Publications

EPHA Position on Medicine Shortages

EPHA Response to public consultation on EMA Regulatory Science to 2025

BeNeLuxA et al.: the best is yet to come

Latest Developments

Getting it right: COVID19 vaccines procurement

How should the European Commission and Member States manage the process of finding vaccines to tackle COVID-19? EPHA sets out 9 recommendations the European Commission and national governments should full to protect the public interest.

read more

Analysis & Opinion

Get monthly updates on key public health issues!

Events

Time for a new deal

14 November 2019

4th EPHA Universal Access and Affordable Medicines Forum. Challenging the status quo on medicines policy.

Past events

Putting health first

3 June 2019

Trailblazers, routes to better and affordable medicines by 2025

20 November 2018

How good are our medicines?

3 October 2018

Game changers for better and affordable medicines in Europe

21 November 2017

At the European Health Forum Gastein

How good are our medicines? An operational agenda for EU & national policy-makers

3 October 2018

Medicines: new games, new rules - Pathways to better and affordable medicines.

5 October 2017

“Healthy" innovation: putting patients before profits

28 September 2016

Do you have a question?

Meet our Universal Access and Affordable Medicines Policy Lead.

Yannis Natsis

Policy Manager
yannis@epha.org
+32 2 233 3886

© 2020 - Development by Simpl.